Prenetics Global EBIT per Share

What does Prenetics Global do? Prenetics Global Ltd generates revenue through its Diagnostics segment, which provides COVID-19 testing services and operates testing laboratories, alongside developing health monitoring systems. The Prevention segment offers genetics testing services to both individuals and corporate entities. The company's primary customers include individuals seeking personal health insights and corporate clients requiring employee health screenings. Revenue streams are derived from testing services and health monitoring system development within the Diagnostics segment, while the Prevention segment focuses on genetic testing for personal and corporate use. The Diagnostics segment's services are utilized by individuals and organizations needing rapid testing solutions, particularly during health crises, while the Prevention segment targets consumers interested in genetic health assessments and businesses implementing wellness programs. Corporate clients in the Prevention segment often engage for bulk employee testing, aligning with workplace health initiatives. The company's business model leverages dual segmentation to address both immediate diagnostic needs and long-term preventive health strategies. Prenetics Global Ltd's revenue is structured around two distinct business areas: diagnostics for acute health monitoring and prevention for genetic health analysis. The Diagnostics segment's operations include laboratory testing and system development, while the Prevention segment delivers personalized genetic testing solutions. Both segments cater to specific market demands, with the Diagnostics segment responding to urgent public health requirements and the Prevention segment supporting proactive health management. Prenetics Global is one of the most popular companies on Eulerpool.